FDA Seeks to Withdraw Approval of Tavneos Over Manipulated Study Data

The FDA is attempting to revoke its approval of the drug Tavneos after discovering that the approval was based on manipulated study data. This raises complex questions about whether patients currently using Tavneos should continue to have access to the medication. The situation highlights challenges regulators face when addressing drug safety and efficacy concerns post-approval.

Originally published by arstechnica